Sublingual immunotherapy

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 3, 2008, Pages 260-264

  Esch, Robert E ^a,b  

^a Research and Development   (United States)

^b Greer Laboratories   (United States)

Author keywords

Allergic rhinitis; Efficacy and safety; Sublingual immunotherapy

Indexed keywords

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ATOPIC DERMATITIS; FOOD ALLERGY; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; CLINICAL TRIALS AS TOPIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 43549107943     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282fc706f     Document Type: Review

References (45)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1:1572-1573.
2. Cohen SG, Evans RE III. Allergen immunotherapy in historical perspective. In: Lockey RF, Bukantz SC, Bousquet J, editors. Allergens and allergen immunotherapy. New York: Marcel Dekker, Inc; 2004. pp. 1-36.
3. Black JH. The oral administration of pollen. J Lab Clin Med 1927; 12: 1156.
4. Morris DL. Use of sublingual antigen in diagnosis and treatment of food allergy. Ann Allergy 1969; 27:289.
5. Taylor G, Shivalkar PR. Local nasal desensitization in allergic rhinitis. Clin Allergy 1975; 5:279-284.
6. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111:437-448.
7. Malling H-J. Sublingual immunotherapy. Clin Exp Allergy 1996; 26:1228-1231.
8. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis [Cochrane Review]. The Cochrane Library 2004; (4).
9. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006; 97:141-148.
10. Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthmatics: systematic review of randomized clinical trials using the Cochrane Collaboration method. Allergy 2006; 61:1162-1172.
11. Passalacqua G, Guerra L, Pasquali M, et al. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol 2004; 93:3-12.
12. Cox LS, Linnemann DL, Nolte H, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117:1021-1035.
13. Canonica GW, Compalati E, Fumagalli F, Passalacqua G. Sublingual and oral immunotherapy. Immunol Allergy Clin North Am 2004; 24:685-704.
14. Moingeon P, Batard T, Fadel R, et al. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006; 61:151-165.
15. Bohle B, Kinaciyan T, Gerstmayr M, et al. Sublingual immunotherapy induces IL-10 producing regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120:707-713.
16. Rossi RE, Monasterolo G, Coco G, et al. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Vaccine 2007; 25:957-964.
17. Allam JP, Niederhagen B, Bucheler M, et al. Comparative analysis of nasal and oral mucosa myeloid dentritic cells. Allergy 2006; 61:166-172.
18. Allam JP, Novak N, Fuchs C, et al. Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcεRI expression. J Allergy Clin Immunol 2003; 112:141-148.
19. Razafindratsita A, Saint-Lu N, Mascarell L, et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 2007; 120:278-285.
20. Yoshitomi T, Nakagami Y, Hirahara K, et al. Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice. J Pept Sci 2007; 13:499-503.
21. Allam JP, Niederhagen B, Appel T, et al. Activation of high affinity receptor for IgE on human oral Langerhans cells leads to the induction of tolerogenic mechanisms. J Allergy Clin Immunol 2006; 117:720.
22. Grosclaude M, Bouillot P, Alt R, et al. Safety of various dosage regimens during induction of sublingual immunotherapy. Int Arch Allergy Immunol 2002; 129:248-253.
23. Vervloet D, Birnbaum J, Laurent P, et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis: a double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007; 142:239-246.
24. Tripodi S, Di Rienzo Businco A, Benincori N, et al. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2006; 139:149-152.
25. Bagnasco M, Mariani G, Passalacqua G, et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes to healthy human beings. J Allergy Clin Immunol 1997; 100:122-129.
26. Bagnasco M, Altrinetti V, Pesce G, et al. Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol 2005; 138:197-202.
27. Bordignon V, Burastero SE. Multiple daily administration of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 2006; 97:158-163.
28. Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma: a placebo-controlled study. Ann Allergy Asthma Immunol 1999; 82:485-490.
29. Khinchi MS, Pulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53.
30. Moingeon P. Sublingual immunotherapy: from biological extracts to recombinant allergens. Allergy 2006; 61 (Suppl 81):15-19.
31. Dahl R, Stender A, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006; 61:185-190.
32. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics 1968; 42:793-802.
33. Des Roches A, Paradis L, Mernardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronussinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99:450-453.
34. De Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003; 33:206-210.
35. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114:851-857.
36. Marogna M, Spadolini I, Massolo A, et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real life: clinical efficacy and more. Allergy 2004; 59:1205-1210.
37. Holt PG, Sly PD. Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol 2007; 7:547-555. The scientific rationale for prophylactic immunotherapy of atopic diseases and early intervention strategies in high-risk infants.
38. Nettis E, Colanardi MC, Soccio AL, et al. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol 2007; 156:674-681.
39. Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007; 120:164-170.
40. Niggemann B, Staden U, Rolinck-Werninghaus C, Beyer K. Specific oral tolerance induction in food allergy. Allergy 2006; 61:808-811.
41. Bousquet J, Lockey RF, Malling HJ. WHO position paper allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl 44):1-42.
42. Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Worshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl):S147-S334.
43. The Technology Evaluation Center: Sublingual immunotherapy for adults. Tec Assessment Program 2003; 18:1-45.
44. Leatherman BD, Owen S, Parker M, et al. Sublingual immunotherapy: past, present, paradigm for the future? Otolaryngol Head Neck Surg 2007; 136 (3 Suppl):S1-S20. A comprehensive and the most recent review of the scientific literature on SLIT.
45. Marogna M, Spadolini I, Massolo A, et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol 2007; 98:274-280.